How long have you owned NWBO? I ask because you have learned nothing in that time. You posted about phase 1 trials (one was even pre-phase 1, how AI will help find personal treatments). It takes a ton of money and years to get from ph 1 to ph 2/3 TLD and then submission to an RA and another year or longer after that. The articles you posted are about pure research. Not relevant to the current situation with NWBO. What part of that don't you understand yet?
The wait on MHRA is indeed frustrating. Once NWBO gets that approval, they still need to execute the commercial rollout. Expect to hear more about dc-vax once it's approved but the main audience will be the very limited number of neurology clinicians in the UK, not the general public. If and when dc-vax-l gets approved, it will be ginormous. Dc-vax-direct might be huge and might get through clinical testing and approval a lot faster, but at this point, the whole enchilada is on DcVax-l finally getting approved, and that's on the MHRA. If you don't understand all that already, sorry to have to say it, but you should never have invested in any individual biotech stock. Whining generally doesn't make anything in life happen more quickly.
Market Data 
Markets 
AI
